Body Dysmorphic Disorder, Psychiatric Symptoms, and Quality of Life in Female Dermatological Patients

Purpose: To examine the relationships of body dysmorphic disorder (BDD) with psychiatric symptoms and quality of life in dermatological patients. Patients and Methods: A total of 154 female patients with dermatological disease underwent a comprehensive clinical assessment that included the Body Dysm...

Full description

Saved in:
Bibliographic Details
Published in:Neuropsychiatric disease and treatment 2020-12, Vol.16, p.2921
Main Authors: Chee, Ik-Seung, Kim, Hyun-Jin, Lee, Young, Kim, Jee Wook
Format: Article
Language:English
Subjects:
Body dysmorphic disorder
Causes of
Complications and side effects
Demographic aspects
Health aspects
Psychiatric research
Psychological aspects
Psychological manifestations of general diseases
Quality of life
Risk factors
Skin diseases
Women
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: To examine the relationships of body dysmorphic disorder (BDD) with psychiatric symptoms and quality of life in dermatological patients. Patients and Methods: A total of 154 female patients with dermatological disease underwent a comprehensive clinical assessment that included the Body Dysmorphic Disorder Examination-Self Report (BDDE-SR), Symptom Checklist 90-Revised (SCL-90-R), and Skindex-29. Dermatological disease was categorized as follows: inflammatory dermatoses (reference category), isolated lesions, and unclassified dermatoses. The BDDE-SR and SCL-90-R scores were used to evaluate BDD and psychiatric symptoms, respectively. Dermatological quality of life was measured with the Skindex-29. Results: The BDDE-SR score was significantly associated with the SCL-90-R and Skindex-29 total and subscores, even after controlling for age, body mass index, and dermatological diagnosis. The variables that contributed most to the BDDE-SR score were the SCL-90-R depression score and Skindex-29 emotion scores. Additional analyses revealed that the BDDE-SR score was higher in participants with unclassified dermatoses, but neither the SCL-90-R score nor Skindex-29 score was related to any dermatological diagnosis. Conclusion: The BDD symptoms were especially prominent in the unclassified dermatoses group and were highly related to psychiatric symptoms and a poor quality of life in our dermatological patients. Further research including studies involving psychiatric interviews to confirm the BDD diagnosis and symptoms will improve our understanding of BDD in dermatological patients. Keywords: body dysmorphic disorder, psychiatric symptoms, quality of life: dermatological disease, unclassified dermatoses
ISSN:1176-6328
DOI:10.2l47/NDT.S284077